Market Research Report
Middle East and Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others
Published by
GlobalData
Published
May 21, 2012
Product code
242664
Content info
Pages: 101
Price
Abstract
Middle East and Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others
Summary
GlobalData's new report, "Middle East and Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the Middle East and Africa Neurology Devices market - Israel, Saudi Arabia and South Africa. The report provides value (USD million) data for all the market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
Countries covered include Israel, Saudi Arabia and South Africa.
Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products .
Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
2011 company shares and distribution shares data for each of the market categories and countries.
Global corporate-level profiles of key companies operating within the Middle East and Africa Neurology Devices market..
Key players covered include Medtronic, Inc., DePuy, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Nihon Kohden Corporation, B. Braun Melsungen AG and others.
Reasons to buy
Develop business strategies by identifying the key market categories and segments poised for strong growth.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the Middle East and Africa Neurology Devices competitive landscape.
Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
TOC
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Neurology Devices in Middle East and Africa 10
3.1 Neurology Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
3.2 Neurology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Neurology Devices, Middle East and Africa, Company share (2010-2011) 18
4 Neurology Devices In South Africa 20
4.1 Neurology Devices, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 20
4.2 Neurology Devices, South Africa, Distribution Share (2010-2011) 26
4.2.1 CSF Management, South Africa, Distribution Share (2010-2011) 26
4.2.2 Interventional Neurology, South Africa, Distribution Share (2010-2011) 26
4.2.3 Neurological Diagnostic Equipment, South Africa, Distribution Share (2010-2011) 27
4.2.4 Neurostimulation Devices, South Africa, Distribution Share (2010-2011) 27
4.2.5 Neurosurgical Products, South Africa, Distribution Share (2010-2011) 28
4.3 Neurology Devices, South Africa, Company Share (2010-2011) 29
4.3.1 Neurology Devices, South Africa, Company Share (2010-2011) 29
4.3.2 CSF Management, South Africa, Company Share (2010-2011) 31
4.3.3 Interventional Neurology, South Africa, Company Share (2010-2011) 32
4.3.4 Neurological Diagnostic Equipment, South Africa, Company Share (2010-2011) 34
4.3.5 Neurostimulation Devices, South Africa, Company Share (2010-2011) 36
4.3.6 Neurosurgical Products, South Africa, Company Share (2010-2011) 37
5 Neurology Devices In Israel 38
5.1 Neurology Devices, Israel, Overall Revenue ($m), USD Constant, 2004-2018 38
5.2 Neurology Devices, Israel, Distribution Share (2010-2011) 44
5.2.1 CSF Management, Israel, Distribution Share (2010-2011) 44
5.2.2 Interventional Neurology, Israel, Distribution Share (2010-2011) 44
5.2.3 Neurological Diagnostic Equipment, Israel, Distribution Share (2010-2011) 45
5.2.4 Neurostimulation Devices, Israel, Distribution Share (2010-2011) 45
5.2.5 Neurosurgical Products, Israel, Distribution Share (2010-2011) 46
5.3 Neurology Devices, Israel, Company Share (2010-2011) 47
5.3.1 Neurology Devices, Israel, Company Share (2010-2011) 47
5.3.2 CSF Management, Israel, Company Share (2010-2011) 49
5.3.3 Interventional Neurology, Israel, Company Share (2010-2011) 51
5.3.4 Neurological Diagnostic Equipment, Israel, Company Share (2010-2011) 52
5.3.5 Neurostimulation Devices, Israel, Company Share (2010-2011) 54
5.3.6 Neurosurgical Products, Israel, Company Share (2010-2011) 55
6 Neurology Devices In Saudi Arabia 57
6.1 Neurology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 57
6.2 Neurology Devices, Saudi Arabia, Distribution Share (2010-2011) 63
6.2.1 Interventional Neurology, Saudi Arabia, Distribution Share (2010-2011) 63
6.2.2 Neurological Diagnostic Equipment, Saudi Arabia, Distribution Share (2010-2011) 64
6.2.3 Neurostimulation Devices, Saudi Arabia, Distribution Share (2010-2011) 64
6.2.4 Neurosurgical Products, Saudi Arabia, Distribution Share (2010-2011) 65
6.3 Neurology Devices, Saudi Arabia, Company Share (2010-2011) 66
6.3.1 Neurology Devices, Saudi Arabia, Company Share (2010-2011) 66
6.3.2 CSF Management, Saudi Arabia, Company Share (2010-2011) 68
6.3.3 Interventional Neurology, Saudi Arabia, Company Share (2010-2011) 70
6.3.4 Neurological Diagnostic Equipment, Saudi Arabia, Company Share (2010-2011) 72
6.3.5 Neurostimulation Devices, Saudi Arabia, Company Share (2010-2011) 74
6.3.6 Neurosurgical Products, Saudi Arabia, Company Share (2010-2011) 75
7 Overview of Key Companies in Middle East and Africa Neurology Devices Market 77
7.1 Medtronic, Inc. 77
7.1.1 Company Overview 77
7.1.2 Share in the Middle East and Africa Neurology Devices Market 77
7.2 DePuy, Inc. 78
7.2.1 Company Overview 78
7.2.2 Share in the Middle East and Africa Neurology Devices Market 78
7.3 St. Jude Medical, Inc. 79
7.3.1 Company Overview 79
7.3.2 Share in the Middle East and Africa Neurology Devices Market 79
7.4 Nihon Kohden Corporation 80
7.4.1 Company Overview 80
7.4.2 Share in the Middle East and Africa Neurology Devices Market 80
7.5 Stryker Corporation 81
7.5.1 Company Overview 81
7.5.2 Share in the Middle East and Africa Neurology Devices Market 81
7.6 B. Braun Melsungen AG 82
7.6.1 Company Overview 82
7.6.2 Share in the Middle East and Africa Neurology Devices Market 83
7.7 Integra LifeSciences Holdings Corporation 84
7.7.1 Company Overview 84
7.8 Terumo Corporation 84
7.8.1 Company Overview 84
7.9 Covidien plc 85
7.9.1 Company Overview 85
7.10 Natus Medical Incorporated 85
7.10.1 Company Overview 85
7.11 Cadwell Laboratories, Inc. 86
7.11.1 Company Overview 86
7.12 CareFusion Corporation 86
7.12.1 Company Overview 86
7.13 Christoph Miethke GmbH & Co. KG 86
7.13.1 Company Overview 86
7.14 Cyberonics, Inc. 87
7.14.1 Company Overview 87
7.15 Boston Scientific Corporation 87
7.15.1 Company Overview 87
7.16 KARL STORZ GmbH & Co. KG 87
7.16.1 Company Overview 87
7.17 Sophysa S.A. 88
7.17.1 Company Overview 88
7.18 Mizuho Ikakogyo Co., Ltd. 88
7.18.1 Company Overview 88
8 Neurology Devices Market Pipeline Products 89
9 Financial Deals Landscape 93
9.1 Acquisition 93
9.1.1 Sorin Group Invests $7 Million In Enopace Biomedical 93
10 Recent Developments 95
10.1 Strategy And Business Planning 95
10.1.1 Jan 21, 2012: CareFusion Opens Middle East Office In Dubai 95
10.2 Government and Public Interest 95
10.2.1 Jan 27, 2012: Elekta Demonstrates Comprehensive Range Of Cancer Management Solutions At 2012 Arab Health Congress And Exhibition 95
10.2.2 Nov 25, 2011: Deymed Diagnostic To Participate In Arab Health 2012 Conference 95
11 Appendix 96
11.1 Definitions of Markets Covered in the Report 97
11.1.1 Neurology Devices 97
11.2 Research Methodology 98
11.3 Secondary Research 98
11.4 Primary Research 99
11.5 Models 99
11.6 Forecasts 100
11.7 Expert Panels 100
11.8 GlobalData Consulting 100
11.9 Currency Conversion 101
11.10 Contact Us 101
11.11 Disclaimer 101
List of Tables
1.1 List of Tables
Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10
Table 2: Neurology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018 12
Table 3: Neurology Devices, Middle East and Africa, Cross-Category Analysis, 2004-2018 13
Table 4: Neurology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 15
Table 5: Neurology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 17
Table 6: Neurology Devices, Middle East and Africa, Company share by Revenue ($m), USD Constant, 2010-2011 19
Table 7: Neurology Devices, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 21
Table 8: Neurology Devices, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 23
Table 9: Neurology Devices, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 25
Table 10: CSF Management, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 26
Table 11: Interventional Neurology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 26
Table 12: Neurological Diagnostic Equipment, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 27
Table 13: Neurostimulation Devices, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 27
Table 14: Neurosurgical Products, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 28
Table 15: Neurology Devices, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 30
Table 16: CSF Management, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 31
Table 17: Interventional Neurology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 33
Table 18: Neurological Diagnostic Equipment, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 35
Table 19: Neurostimulation Devices, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 36
Table 20: Neurosurgical Products, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 37
Table 21: Neurology Devices, Israel, Overall Revenue ($m), USD Constant, 2004-2018 39
Table 22: Neurology Devices, Israel, Overall Revenue ($m), USD Constant, Historic, 2004-2011 41
Table 23: Neurology Devices, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 43
Table 24: CSF Management, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 44
Table 25: Interventional Neurology, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 44
Table 26: Neurological Diagnostic Equipment, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 45
Table 27: Neurostimulation Devices, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 45
Table 28: Neurosurgical Products, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 46
Table 29: Neurology Devices, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 48
Table 30: CSF Management, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 50
Table 31: Interventional Neurology, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 51
Table 32: Neurological Diagnostic Equipment, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 53
Table 33: Neurostimulation Devices, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 54
Table 34: Neurosurgical Products, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 56
Table 35: Neurology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 58
Table 36: Neurology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 60
Table 37: Neurology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 62
Table 38: CSF Management, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 63
Table 39: Interventional Neurology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 63
Table 40: Neurological Diagnostic Equipment, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 64
Table 41: Neurostimulation Devices, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 64
Table 42: Neurosurgical Products, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 65
Table 43: Neurology Devices, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 67
Table 44: CSF Management, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 69
Table 45: Interventional Neurology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 71
Table 46: Neurological Diagnostic Equipment, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 73
Table 47: Neurostimulation Devices, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 74
Table 48: Neurosurgical Products, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 76
Table 49: Neurology Devices Market Pipeline Products 89
Table 50: Sorin Group Invests $7 Million In Enopace Biomedical 93
List of Figures
1.2 List of Figures
Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
Figure 2: Neurology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Neurology Devices, Middle East and Africa, Cross-Category Analysis, 2004-2018 13
Figure 4: Neurology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 14
Figure 5: Neurology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 16
Figure 6: Neurology Devices, Middle East and Africa, Company share (%), 2011 18
Figure 7: Neurology Devices, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 20
Figure 8: Neurology Devices, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 22
Figure 9: Neurology Devices, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 24
Figure 10: Neurology Devices, South Africa, Company Share (%), 2011 29
Figure 11: CSF Management, South Africa, Company Share (%), 2011 31
Figure 12: Interventional Neurology, South Africa, Company Share (%), 2011 32
Figure 13: Neurological Diagnostic Equipment, South Africa, Company Share (%), 2011 34
Figure 14: Neurostimulation Devices, South Africa, Company Share (%), 2011 36
Figure 15: Neurosurgical Products, South Africa, Company Share (%), 2011 37
Figure 16: Neurology Devices, Israel, Overall Revenue ($m), USD Constant, 2004-2018 38
Figure 17: Neurology Devices, Israel, Overall Revenue ($m), USD Constant, Historic, 2004-2011 40
Figure 18: Neurology Devices, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 42
Figure 19: Neurology Devices, Israel, Company Share (%), 2011 47
Figure 20: CSF Management, Israel, Company Share (%), 2011 49
Figure 21: Interventional Neurology, Israel, Company Share (%), 2011 51
Figure 22: Neurological Diagnostic Equipment, Israel, Company Share (%), 2011 52
Figure 23: Neurostimulation Devices, Israel, Company Share (%), 2011 54
Figure 24: Neurosurgical Products, Israel, Company Share (%), 2011 55
Figure 25: Neurology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 57
Figure 26: Neurology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 59
Figure 27: Neurology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 61
Figure 28: Neurology Devices, Saudi Arabia, Company Share (%), 2011 66
Figure 29: CSF Management, Saudi Arabia, Company Share (%), 2011 68
Figure 30: Interventional Neurology, Saudi Arabia, Company Share (%), 2011 70
Figure 31: Neurological Diagnostic Equipment, Saudi Arabia, Company Share (%), 2011 72
Figure 32: Neurostimulation Devices, Saudi Arabia, Company Share (%), 2011 74
Figure 33: Neurosurgical Products, Saudi Arabia, Company Share (%), 2011 75
Figure 34: Medtronic, Inc., Company Share (%), Middle East and Africa Neurology Devices Market, 2011 77
Figure 35: DePuy, Inc., Company Share (%), Middle East and Africa Neurology Devices Market, 2011 78
Figure 36: St. Jude Medical, Inc., Company Share (%), Middle East and Africa Neurology Devices Market, 2011 79
Figure 37: Nihon Kohden Corporation, Company Share (%), Middle East and Africa Neurology Devices Market, 2011 80
Figure 38: Stryker Corporation, Company Share (%), Middle East and Africa Neurology Devices Market, 2011 81
Figure 39: B. Braun Melsungen AG, Company Share (%), Middle East and Africa Neurology Devices Market, 2011 83
Middle East and Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others published by GlobalData in May 21, 2012. This report consists of Pages: 101 and the price starts from US $ 3500.
Int'l +1-860-674-8796
Toll Free (US) +1-866-353-3335
Europe +32-2-535-7543
Asia Pacific +65-6223-2436